Open AccessState‐of‐the‐art consensus on non‐transvenous implantable cardioverter‐defibrillator therapy
Author(s) -
Schukro Christoph,
Santer David,
Prenner Günther,
Stühlinger Markus,
Martinek Martin,
Teubl Alexander,
Moertl Deddo,
Schwarz Stefan,
Nürnberg Michael,
Fiedler Lukas,
Hatala Robert,
Khazen Cesar
Publication year - 2020
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.23432
Subject(s) - medicine , implantable cardioverter defibrillator , complication , intensive care medicine , shock (circulatory) , randomized controlled trial , surgery , medical emergency , cardiology
Abstract Within the last decade, implantable cardioverter‐defibrillator (ICD) systems with non‐transvenous leads were developed in order to minimize complications related to the cardiovascular position of transvenous ICD leads. This national expert consensus gives an overview of potential indications for the implantation of non‐transvenous ICD systems, and provides specific recommendations for implantation, follow‐up, and complication management in patients with subcutaneous ICD. Regarding particular issues like the necessity for shock efficacy testing, or the clinical outcome as compared to transvenous ICD, randomized data are expected in the near future.